Tagamox BN
Tagamox BN Products are primarily used for
Bacterial infections, Post operative pain
About Tagamox BN Products
Uses of Tagamox BN Products
Bromfenac+Moxifloxacin is used in bacterial infections and post operative pain.
Tagamox BN Products side effects
Severe
Side Effects of Tagamox BN are Eye irritation, Abnormal sensation in eyes, Anaphylactic reaction, Anterior chamber eye hemorrhage, Burning sensation, Conjunctival hyperemia, Corneal erosion, Corneal perforations, Corneal thinning, Corneal ulcer, Epithelial keratopathy, Eye pain, Eye itching, Eye redness, Headache, Hypersensitivity, Iritis keratitis, Prolonged bleeding, Stinging sensation, Conjunctival irritation, Reduced visual acuity, Taste change, Eye discharge, Eyelid swelling, Increased lacrimation, Papillary conjunctivitis, Fever, Subconjunctival hemorrhage, Teary eyes.
How Tagamox BN Products work
Bromfenac + Moxifloxacin is a combination of two medicines: Bromfenac + Moxifloxacin1 and Bromfenac + Moxifloxacin2 which treat eye infections. Bromfenac + Moxifloxacin1 is a non-steroidal anti-inflammatory drug (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling) in the eye. Bromfenac + Moxifloxacin2 is an antibiotic. It kills bacteria by preventing them from reproducing and repairing themselves.
Patient Concerns about Tagamox BN Products
Frequently asked questions about Tagamox BN Products
Frequently asked questions about Tagamox BN Products
Q. How long does Tagamox BN Eye Drop takes to work?
Usually, Tagamox BN Eye Drop starts working soon after applying it. However, it may take some days to kill all the harmful bacteria and make you feel better.
Q. Can I stop applying Tagamox BN Eye Drop when I feel better?
No, do not stop applying Tagamox BN Eye Drop and complete the full course of treatment even if you feel better. Your symptoms may improve before the infection is completely cured.
Products for Tagamox BN
Tagamox BN Eye Drop
bottle of 5 ml Eye Drop
MRP
₹169
Not Available